April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational botensilimab/balstilimab combination in relapsed/refractory sarcoma
Oct 23, 2023, 13:31

At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational botensilimab/balstilimab combination in relapsed/refractory sarcoma

Agenus shared on their LinkedIn page:

“At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational botensilimab/balstilimab (BOT/BAL) combination in relapsed/refractory sarcoma, which showed durable responses across multiple subtypes. The results reinforce the potential of BOT/BAL in multiple cold, treatment-resistant solid tumors. Learn more here.”

Source: Agenus/LinkedIn